مروری بر بیماری کووید-19

نویسنده

کرمان، دانشگاه شهید باهنر کرمان، دانشکده علوم، گروه زیست شناسی

چکیده

ظهور و گسترش 2019CORONAVIRUS که به عنوان یک بحران بهداشتی تهدید کننده  از سال 2019 تاکنون ادامه داشته هم اکنون در حال تهدید جدی جهان است. این ویروس از خفاش ها منشأ گرفته و با میزبان های واسط  ناشناخته که گروهی از حیوانات هستند، در ووهان ،مرکز شهر هوبی چین در دسامبر سال 2019  به انسان منتقل شد.

کلیدواژه‌ها

  1. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020
  2. Coronavirus Outbreak. Available at: https://www.worldometers.info/coronavirus/. Accessed 23 Feb 2020.
  3. Richman DD, Whitley RJ, Hayden FG. Clinical Virology, 4th ed. Washington: ASM Press; 2016.
  4. Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology. 2003;8:S9-14
  5. Middle East Respiratory Syndrome Coronavirus. Available at: https://www.who.int/emergencies/mers-cov/en/. Accessed 16 Feb 2020.
  6. World Health Organization. Situation reports. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/ . Accessed 22 Feb 2020.
  7. Xinhua. China’s CDC detects a large number of new coronaviruses in the South China seafood market in Wuhan. Available at: https://www.xinhuanet.com/2020-01/27/c_1125504355.htm . Accessed 20 Feb 2020.
  8. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395: 497–506.
  9. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. NEngl J Med. 2020.

 

 

 

  1. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med.2020
  2. Cheng ZJ, Shan J. 2019 novel coronavirus: where we are and what we know. Infection. 2020:1–9.
  3. Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020.
  4. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. J Hosp Infect. 2020 Feb 6. pii: S0195–6701(20)30046–3.
  5. Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet.2020.
  6. characteristics of 99 cases of 2019 novel Chen N, Zhou M, Dong X, et al. Epidemiological and clinical coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.
  7. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Wuhan, China. JAMA. 2020. coronavirus–infected pneumonia in
  8. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368: m606.
  9. Wang XF, Yuan J, Zheng YJ, et al. Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen. [Article in Chinese]. Zhonghua Er Ke Za Zhi. 2020;58:E008.
  10. Chen F, Liu ZS, Zhang FR, et al. First case of severe childhood novel coronavirus pneumonia in China. Zhonghua Er Ke Za Zhi. 2020;58:E005.
  11. Zeng LK, Tao XW, Yuan WH, Wang J, Liu X, Liu ZS. First case of neonate infected with novel coronavirus pneumonia in China. Zhonghua Er Ke Za Zhi. 2020;58:E009.
  12. in YH, Cai L, Cheng ZS, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus [2019-nCoV] infected pneumonia [standard version]. Mil Med Res. 2020;7:4.
  13. Huang P, Liu T, Huang L, et al. Use of chest CTin combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion. Radiology. 2020.
  14. Chen Z-M, Fu J-F, Shu Q, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr. 2020:1–7.
  15. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395:473–5.
  16. Zhao JP, Hu Y, Du RH, et al. Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia. Zhonghua JieHeHe Hu Xi ZaZhi.2020;43:E007.
  17. WHO. Clinical management of severe acute respiratory infection when novel coronavirus [nCoV] infection is suspected. Available at: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novelcoronavirus-[ncov]-infection-is-suspected . Accessed 9 Feb 2020.
  18. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020.
  19. Zhang L, Liu Y. Potential interventions for novel coronavirus in China: a systemic review. J Med Virol. 2020.
  20. Multicenter Collaboration Group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for Chloroquine in the Treatment of Novel Coronavirus Pneumonia. [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]. [Article in Chinese] Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E019.
  21. World Health Organization. Coronavirus disease [COVID-19] Technical Guidance: Infection Prevention and Control. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/infection-prevention-and-control. Accessed 20 Feb 2020.
  22. Chang D, Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med. 2020.
  23. Li J, Li J, Xie X, et al. Game consumption and the 2019 novel coronavirus. Lancet Infect Dis. 2020.
  • تاریخ دریافت: 22 فروردین 1398
  • تاریخ بازنگری: 10 اسفند 1398
  • تاریخ پذیرش: 10 اسفند 1398